Sulku, Johanna http://orcid.org/0000-0002-1444-752X
Bröms, Kristina
Högman, Marieann
Janson, Christer
Lisspers, Karin
Malinovschi, Andrei http://orcid.org/0000-0002-4098-7765
Melhus, Håkan
Ställberg, Björn http://orcid.org/0000-0001-8497-7326
Nielsen, Elisabet I. http://orcid.org/0000-0003-0725-214X
Funding for this research was provided by:
Uppsala-Örebro Regional Research Council, Centre for Research & Development, Uppsala university/Region Gävleborg, Bror Hjerpstedt Foundation, Uppsala County Association Against Heart and Lung Diseases
Uppsala-Örebro Regional Research Council; Centre for Research & Development, Uppsala University/Region Gävleborg
Uppsala-Örebro Regional Research Council; Centre for Research & Development, Uppsala University/Region Gävleborg; Swedish Heart-Lung Foundation
Uppsala-Örebro Regional Research Council, County Council Dalarna
Uppsala-Örebro Regional Research Council, Centre for Clinical Research, Uppsala University, the Swedish Heart-Lung Foundation, the Swedish Heart and Lung Association
Article History
Received: 15 October 2020
Accepted: 6 January 2021
First Online: 9 February 2021
Competing interests
: J.S., K.B., M.H., H.M. and E.I.N. have no conflict of interests to report. C.J. has received payments for educational activities from AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Novartis and Teva, and has served on advisory boards arranged by AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Novartis and Teva. K.L. has received payments for educational activities from Novartis, TEVA, Boehringer Ingelheim and AstraZeneca, and served on advisory boards arranged by AstraZeneca, GlaxoSmithKline and Boehringer Ingelheim. A.M. has received research support from Chiesi and lecture fees from AstraZeneca, none of them related to pharmacological treatment. B.S. has received honoraria for educational activities and lectures from AstraZeneca, Boehringer Ingelheim, Novartis, MEDA, Chiesi and TEVA, and has served on advisory boards arranged by AstraZeneca, Novartis, GlaxoSmithKline, Boehringer Ingelheim, Teva and MEDA.